BioCentury
ARTICLE | Financial News

InMed proposes follow-on

April 28, 2017 7:00 PM UTC

On April 21, cannabinoid-based therapeutics developer InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF) proposed a follow-on underwritten by Canaccord Genuity and Roth Capital Partners....

BCIQ Company Profiles

InMed Pharmaceuticals Inc.